These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 33748133)
1. Immune-Related Long Non-coding RNA Signature and Clinical Nomogram to Evaluate Survival of Patients Suffering Esophageal Squamous Cell Carcinoma. Zhu T; Ma Z; Wang H; Wei D; Wang B; Zhang C; Fu L; Li Z; Yu G Front Cell Dev Biol; 2021; 9():641960. PubMed ID: 33748133 [TBL] [Abstract][Full Text] [Related]
2. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma. Li W; Liu J; Zhao H Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896 [TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Prognostic Gene Signature Correlated With M2 Macrophage Infiltration in Esophageal Squamous Cell Carcinoma. Yao J; Duan L; Huang X; Liu J; Fan X; Xiao Z; Yan R; Liu H; An G; Hu B; Ge Y Front Oncol; 2021; 11():769727. PubMed ID: 34926275 [TBL] [Abstract][Full Text] [Related]
4. The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma. Liu Y; Wang L; Liu H; Li C; He J Front Oncol; 2020; 10():61. PubMed ID: 32133283 [No Abstract] [Full Text] [Related]
5. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma. Zhao F; Li Z; Dong Z; Wang Z; Guo P; Zhang D; Li S Front Immunol; 2022; 13():918154. PubMed ID: 35880180 [TBL] [Abstract][Full Text] [Related]
6. A novel immune-related radioresistant lncRNAs signature based model for risk stratification and prognosis prediction in esophageal squamous cell carcinoma. Zheng J; Chen X; Huang B; Li J Front Genet; 2022; 13():921902. PubMed ID: 36147506 [No Abstract] [Full Text] [Related]
7. Identification of Prognostic Glycolysis-Related lncRNA Signature in Tumor Immune Microenvironment of Hepatocellular Carcinoma. Bai Y; Lin H; Chen J; Wu Y; Yu S Front Mol Biosci; 2021; 8():645084. PubMed ID: 33968985 [No Abstract] [Full Text] [Related]
8. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma. Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459 [TBL] [Abstract][Full Text] [Related]
9. Development and Validation of a Ferroptosis-Related Gene Signature and Nomogram for Predicting the Prognosis of Esophageal Squamous Cell Carcinoma. Ye J; Wu Y; Cai H; Sun L; Deng W; Liang R; Han A Front Genet; 2021; 12():697524. PubMed ID: 34764976 [TBL] [Abstract][Full Text] [Related]
10. Protein-coding genes combined with long non-coding RNAs predict prognosis in esophageal squamous cell carcinoma patients as a novel clinical multi-dimensional signature. Guo JC; Li CQ; Wang QY; Zhao JM; Ding JY; Li EM; Xu LY Mol Biosyst; 2016 Oct; 12(11):3467-3477. PubMed ID: 27714034 [TBL] [Abstract][Full Text] [Related]
11. Construction of the Six-lncRNA Prognosis Signature as a Novel Biomarker in Esophageal Squamous Cell Carcinoma. Zheng ZJ; Li YS; Zhu JD; Zou HY; Fang WK; Cui YY; Xie JJ Front Genet; 2022; 13():839589. PubMed ID: 35432441 [TBL] [Abstract][Full Text] [Related]
12. A Prognostic Signature Based on Immunogenomic Profiling Offers Guidance for Esophageal Squamous Cell Cancer Treatment. Gao J; Tang T; Zhang B; Li G Front Oncol; 2021; 11():603634. PubMed ID: 33718151 [TBL] [Abstract][Full Text] [Related]
13. Risk Stratification and Validation of Eleven Autophagy-Related lncRNAs for Esophageal Squamous Cell Carcinoma. Zhao X; Wang Y; Meng F; Liu Z; Xu B Front Genet; 2022; 13():894990. PubMed ID: 35832188 [TBL] [Abstract][Full Text] [Related]
14. A Novel Autophagy-Related Long Non-Coding RNA Signature to Predict Prognosis and Therapeutic Response in Esophageal Squamous Cell Carcinoma. Shi X; Liu X; Pan S; Ke Y; Li Y; Guo W; Wang Y; Ruan Q; Zhang X; Ma H Int J Gen Med; 2021; 14():8325-8339. PubMed ID: 34815705 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of Molecular Clusters and Prognostic Signature Based on m7G-related LncRNAs in Esophageal Squamous Cell Carcinoma. Zhao F; Dong Z; Li Y; Liu S; Guo P; Zhang D; Li S Front Oncol; 2022; 12():893186. PubMed ID: 35912250 [TBL] [Abstract][Full Text] [Related]
16. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer. Fan Q; Liu B Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of a five-lncRNA signature in esophageal squamous cell carcinoma. Zhang L; Li P; Liu E; Xing C; Zhu D; Zhang J; Wang W; Jiang G Cancer Cell Int; 2020; 20():386. PubMed ID: 32831646 [TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of lncRNAs, miRNAs, and mRNAs forming a prognostic scoring system in esophageal squamous cell carcinoma. Shi X; Li Y; Sun Y; Zhao X; Sun X; Gong T; Liang Z; Ma Y; Zhang X PeerJ; 2020; 8():e8368. PubMed ID: 32095316 [TBL] [Abstract][Full Text] [Related]
19. A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma. Huang G; Huang Q; Xie Z; Zhou H; Cao J; Shi L; Yang M Cancer Biomark; 2019; 26(3):239-247. PubMed ID: 31524143 [TBL] [Abstract][Full Text] [Related]
20. An Immune-Related Long Non-Coding RNA Signature to Predict the Prognosis of Ewing's Sarcoma Based on a Machine Learning Iterative Lasso Regression. Ren EH; Deng YJ; Yuan WH; Zhang GZ; Wu ZL; Li CY; Xie QQ Front Cell Dev Biol; 2021; 9():651593. PubMed ID: 34124041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]